Due to health issues, this site is no longer maintained and will be shut down shortly. |
Koninklijke Philips N.V. operates as a health technology company worldwide. It operates through Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and HealthTech Other segments. The company offers mother and child care, and oral healthcare products; male grooming and beauty products; kitchen appliance, coffee, air, garment care, and floor care products; and sleep, respiratory care, and respiratory drug delivery products. It also provides diagnostic x-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. In addition, the company offers interventional x-ray systems, and imaging and therapy devices for coronary artery and peripheral vascular disease; imaging products; guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; and proprietary software to enable diagnostics and intervention. Further, it provides enterprise wide patient monitoring solutions; patient analytics and monitoring, and clinical decision support systems; therapeutic care products; patient monitoring and therapeutic care consumables; and customer services. Additionally, the company offers healthcare information technology (IT), clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology departments; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. It also provides HealthSuite Cloud, Premise, Insights, Consumer Engagement, and Clinical platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.This company has ADRs that trade in the U.S. as the symbol PHG.
14.95 EUR
As of 01/19/2023
2022 © Stock Market MBA, Inc.